ORALE CANNABINOID-REZEPTORMODULATORFORMULIERUNGEN
European patent · EP3735239 · In force
Register entry
- Publication number
- EP3735239
- Application number
- EP19705249
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jan 7, 2019
- Published
- Nov 11, 2020
- Granted
- May 6, 2026
- Protection ends at the latest
- Jan 6, 2039
- Next annual fee due
- Jan 31, 2027
- IPC classes
- A61K 31/4525 (2006.01)A61K 9/20 (2006.01)A61P 25/30 (2006.01)A61P 25/02 (2006.01)A61P 35/00 (2006.01)
- Priority
- US 201815862721 05.01.2018
- PCT application
- PCT/US2019/012459 07.01.2019
- PCT publication
- WO2019/136331 11.07.2019
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- May 6, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 06.05.2026
Parties
Inventor
FOSS, Joseph
Cleveland, Ohio 44195, US
ATTALA, Mohamed Naguib
Cleveland, Ohio 44195, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.